Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -5.3e-05 | 1 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -3.5e-05 | 1 |